 |
|
Chronic, Multiple Tics of Gilles de la Tourette's DiseaseCSF Acid Monoamine Metabolites After Probenecid Administration
Donald J. Cohen, MD;
Bennett A. Shaywitz, MD;
Barbara Caparulo;
J. Gerald Young, MD;
Malcolm B. Bowers, Jr, MD
Arch Gen Psychiatry. 1978;35(2):245-250.
Abstract
• Central nervous system metabolism in six children and one adult with the syndrome of chronic multiple tics was studied by measuring the accumulation of acid metabolites of dopamine and serotonin (homovanillic acid [HVA] and 5-hydroxyindoleacetic acid [5-HIAA], respectively) in the CSF following probenecid administration. The accumulation of 5-HIAA was reduced in patients with multiple tics in contrast with other pediatric patients (N = 27). The degree of reduction in 5-HIAA relative to HVA appeared to be associated with the severity of the tic disorder. With dextroamphetamine, tic symptoms worsened, CSF HVA level decreased, and CSF 5-HIAA concentration increased. These findings suggest an association in Gilles de la Tourette's disease of reduced functioning of inhibitory serotonergic mechanisms and functional dopaminergic overactivity.
Author Affiliations
From the Departments of Pediatrics (Drs Cohen, Shaywitz, and Young), Psychiatry (Drs Cohen, Young, and Bowers), Psychology (Dr Cohen), and Neurology (Dr Shaywitz), and the Child Study Center (Drs Cohen and Young and Ms Caparulo), Yale University School of Medicine, New Haven, Conn.
Footnotes
Accepted for publication June 20, 1977.
Reprint requests to Child Study Center, Yale University, 333 Cedar St, New Haven, CT 06510 (Dr Cohen).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
CENTRAL NERVOUS SYSTEM SEROTONIN AND PERSONALITY AS VARIABLES CONTRIBUTING TO EXCESSIVE ALCOHOL CONSUMPTION IN NON-HUMAN PRIMATES
Higley and Bennett
Alcohol Alcohol 1999;34:402-418.
ABSTRACT
| FULL TEXT
Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an update
Baker et al.
J Psychopharmacol 1995;9:273-280.
ABSTRACT
Gilles de la Tourette Syndrome Is Not Linked to D2-Dopamine Receptor
Gelernter et al.
Arch Gen Psychiatry 1990;47:1073-1077.
ABSTRACT
Specificity of Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: Comparison of Fluvoxamine and Desipramine
Goodman et al.
Arch Gen Psychiatry 1990;47:577-585.
ABSTRACT
Gilles de la Tourette's Syndrome: A Review of Clinical and Research Studies and Consideration of Future Directions for Investigation
Caine
Arch Neurol 1985;42:393-397.
ABSTRACT
Tourette's Syndrome and Migraine
Barabas et al.
Arch Neurol 1984;41:871-872.
ABSTRACT
Neuroanatomy of Gilles de la Tourette's Syndrome Possible Midbrain Involvement
Devinsky
Arch Neurol 1983;40:508-514.
ABSTRACT
Familial Pattern of Gilles de la Tourette Syndrome
Kidd et al.
Arch Gen Psychiatry 1980;37:1336-1339.
ABSTRACT
Clonidine Ameliorates Gilles de la Tourette Syndrome
Cohen et al.
Arch Gen Psychiatry 1980;37:1350-1357.
ABSTRACT
Deleterious Effects of Drugs Used for Hyperactivity on Patients with Gilles de la Tourette Syndrome
Sleator
CLIN PEDIATR 1980;19:453-454.
ABSTRACT
CSF Monoamine Metabolites in Child and Adult Psychiatric Patients: A Developmental Perspective
Leckman et al.
Arch Gen Psychiatry 1980;37:677-681.
Effects of Dopamine Agonists and Antagonists in Tourette's Disease
Feinberg and Carroll
Arch Gen Psychiatry 1979;36:979-985.
ABSTRACT
|
